Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
29 hedge funds and large institutions have $1.33M invested in Histogen Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 9 closing their positions.
140% more call options, than puts
Call options by funds: $24K | Put options by funds: $10K
3% less capital invested
Capital invested by funds: $1.38M → $1.33M (-$46K)
19% less funds holding
Funds holding: 36 → 29 (-7)
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$115K |
| 2 |
LPL Financial
San Diego,
California
|
+$1.96K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$1.63K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$717 |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
+$261 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$167K |
| 2 |
BlackRock
New York
|
-$105K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$25K |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$24K |
| 5 |
VF
Virtu Financial
New York
|
-$23.3K |
HSTO Hedge Fund Activity: Q3 2019 in Review
29 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q3 2019, worth a combined $1.33M — down 3.3% from $1.38M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of HSTO and 2 opened new positions — a net loss of 7 holders — while 11 trimmed existing stakes and 4 added.
The largest buyer was Acadian Asset Management, adding an estimated $115K. The largest seller was Vanguard Group, cutting an estimated $167K.
- 29 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q3 2019, down from 36 in Q2 2019.
- Funds reported $1.33M of Histogen Inc. Common Stock stock for Q3 2019, down 3.3% quarter-over-quarter.
- 2 funds opened new Histogen Inc. Common Stock positions in Q3 2019 and 9 closed out, a net change of -7 holders.
- The largest Histogen Inc. Common Stock buyer in Q3 2019 was Acadian Asset Management, an estimated $115K added.
- The largest Histogen Inc. Common Stock seller in Q3 2019 was Vanguard Group, an estimated $167K sold.
Based on aggregated 13F filings for Q3 2019.